Beleave Inc.

BLEVFOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$566

P/E Ratio—

52W High$0.0001

52W Low$0.000001

Avg Volume2K

Open$0.00

Beta-148.45

Free Cash Flow Financials Revenue

Beleave Inc. (BLEVF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

BLEVF · free cash flow · updated Jun 9, 2026

Core FCF metrics

BLEVF · FCF · TTM · margin & CAGR

Free cash flow was −$17.3M for FY2019 (fiscal year ending 2019-03-31), down 128.9% year-over-year The FCF margin was -729.0%.

FY2019 Free Cash Flow−$17.3M▼ -128.9% YoY

Trailing 12M (TTM)$5.6MTrailing 4Q sum · TTM positive vs latest FY negative

FCF Margin-729.0%−$17.3M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

BLEVF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2019Latest−$9.5M(8M)−$17.3M▼ 128.9%-729.0%

FY2018−$5.9M(2M)−$7.6M▼ 233.8%—

FY2017−$1.3M(1M)−$2.3M▼ 459.5%—

FY2016−$365,502(0M)−$404,812▲ +67.2%—

FY2015−$371,867(1M)−$1.2M▼ 5564.2%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

BLEVF · P/FCF · FCF yield · FCF per share

Beleave Inc. (BLEVF) trades at a FCF yield of -2194724.30% and a price-to-free-cash-flow ratio of 0.0x. FCF per share stands at $0.01, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

-2194724.30%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.01

TTM FCF ÷ Shares Outstanding

Price / FCF

x0.0

Share Price ÷ FCF per Share

EV / FCF (TTM)

x-0.6

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2019 · 2019-03-31

Cash flow statement summary

BLEVF · cash flow statement · operating / investing / financing

For FY2019, Beleave Inc. generated −$9.5M in operating cash flow and spent 8M in capital expenditures, yielding −$17.3M in free cash flow.

Operating Activities

−$9.5M

Cash from core business operations

2019-03-31

Investing Activities

−$9.0M

CapEx, acquisitions & investments

2019-03-31

Financing Activities

+$7.0M

Buybacks, dividends & debt

2019-03-31

FCF FormulaOperating CF (−$9.5M) − |CapEx| (8M) = FCF (−$17.3M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

BLEVF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Beleave Inc.YOU

BLEVF

−$17.3M-128.9%-729.0%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Beleave Inc. (BLEVF) reported free cash flow of −$17.3M for FY2019 (fiscal year ending 2019-03-31), down 128.9% year-over-year. The FCF margin was -729.0%.

Beleave Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 15 fiscal years.

Beleave Inc.'s FCF yield is -2194724.30% and price-to-FCF ratio is 0.0x for FY2019, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

BLEVF free cash flow · 8 questions

Beleave Inc. free cash flow was −$17.3M for FY2019, down 128.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $5.6M.

BLEVF free cash flowBLEVF FCFBLEVF FCF 2019BLEVF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Beleave Inc. · Beleave Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026